Skip to main content
Top
Published in: Cardiovascular Drugs and Therapy 1/2010

01-02-2010

The PACIFIC (Prevention of AtherothrombotiC Incidents Following Ischemic Coronary attack) Registry: Rationale and Design of a 2-Year Study in Patients Initially Hospitalised with Acute Coronary Syndrome in Japan

Authors: Katsumi Miyauchi, Yoshihiro Morino, Kengo Tsukahara, Hideki Origasa, Hiroyuki Daida, on behalf of the PACIFIC steering committee members

Published in: Cardiovascular Drugs and Therapy | Issue 1/2010

Login to get access

Abstract

Purpose

Atherothrombotic disease is a major and increasing health problem in Japan. Effective secondary prevention of atherothrombotic events after acute coronary syndrome (ACS) is required, but clinical evidence regarding the current state of preventive treatment and the rate of subsequent atherothrombotic events after ACS in Japan is limited. Up-to-date Japanese epidemiological real world data are required to construct optimal evidence-based Japanese guidelines for the management of patients with ACS.

Methods

The PACIFIC (Prevention of AtherothrombotiC Incidents Following Ischemic Coronary attack) Registry is an ongoing, observational study of a large cohort of Japanese patients hospitalised with any manifestation of ACS (ST-segment elevation myocardial infarction, non-ST-segment elevation myocardial infarction or unstable angina [UA]). Up to 4,000 patients from approximately 100 sites nationwide will be enrolled and the primary study endpoint is the incidence of any major atherothrombotic event (cardiovascular, cerebrovascular or peripheral) between the initial ACS event and 2 years of follow-up. Secondary endpoints include fatal myocardial infarction (MI), fatal stroke, other cardiovascular death, non-cardiovascular death, non-fatal MI/UA, non-fatal stroke and acute peripheral arterial occlusion. Hospitalisation for vascular interventions will also be recorded, as will haemorrhage requiring hospitalisation or blood transfusion. The use of preventive treatment will also be reported and different patient subgroups (diabetes mellitus, hypertension, dyslipidaemia and metabolic syndrome) will be analysed. It is expected that the study will be completed in early to mid 2011.

Conclusions

The PACIFIC Registry will give insights as to the Japanese epidemiology of ACS: recurrence of atherothrombotic events in the same or other vascular territories.
Appendix
Available only for authorised users
Literature
1.
go back to reference Drouet L. Atherothrombosis as a systemic disease. Cerebrovasc Dis. 2002;13:S1–6.CrossRef Drouet L. Atherothrombosis as a systemic disease. Cerebrovasc Dis. 2002;13:S1–6.CrossRef
2.
go back to reference Bhatt DL. Diffuse coronary disease and atherothrombosis: a rationale for long-term therapy to prevent recurrent ischemic events. J Invasive Cardiol. 2003;15:3B–9. discussion B–10B.PubMed Bhatt DL. Diffuse coronary disease and atherothrombosis: a rationale for long-term therapy to prevent recurrent ischemic events. J Invasive Cardiol. 2003;15:3B–9. discussion B–10B.PubMed
3.
go back to reference Meadows TA, Bhatt DL. Clinical aspects of platelet inhibitors and thrombus formation. Circ Res. 2007;100:1261–75.CrossRefPubMed Meadows TA, Bhatt DL. Clinical aspects of platelet inhibitors and thrombus formation. Circ Res. 2007;100:1261–75.CrossRefPubMed
4.
go back to reference Viles-Gonzalez JF, Fuster V, Badimon JJ. Atherothrombosis: a widespread disease with unpredictable and life-threatening consequences. Eur Heart J. 2004;25:1197–207.CrossRefPubMed Viles-Gonzalez JF, Fuster V, Badimon JJ. Atherothrombosis: a widespread disease with unpredictable and life-threatening consequences. Eur Heart J. 2004;25:1197–207.CrossRefPubMed
5.
go back to reference Kubo M, Kiyohara Y, Kato I, et al. Trends in the incidence, mortality, and survival rate of cardiovascular disease in a Japanese community: the Hisayama study. Stroke. 2003;34:2349–54.CrossRefPubMed Kubo M, Kiyohara Y, Kato I, et al. Trends in the incidence, mortality, and survival rate of cardiovascular disease in a Japanese community: the Hisayama study. Stroke. 2003;34:2349–54.CrossRefPubMed
6.
go back to reference Yoshiike N, Seino F, Tajima S, et al. Twenty-year changes in the prevalence of overweight in Japanese adults: the National Nutrition Survey 1976–95. Obes Rev. 2002;3:183–90.CrossRefPubMed Yoshiike N, Seino F, Tajima S, et al. Twenty-year changes in the prevalence of overweight in Japanese adults: the National Nutrition Survey 1976–95. Obes Rev. 2002;3:183–90.CrossRefPubMed
7.
go back to reference Adachi H, Hino A, Imaizumi T. Prediction of cardiovascular morbidity and mortality based on changes of cholesterol levels in Japan. Cardioangiology. 2005;57:15–20. Adachi H, Hino A, Imaizumi T. Prediction of cardiovascular morbidity and mortality based on changes of cholesterol levels in Japan. Cardioangiology. 2005;57:15–20.
8.
go back to reference Jemal A, Ward E, Hao Y, Thun M. Trends in the leading causes of death in the United States, 1970–2002. JAMA. 2005;294:1255–9.CrossRefPubMed Jemal A, Ward E, Hao Y, Thun M. Trends in the leading causes of death in the United States, 1970–2002. JAMA. 2005;294:1255–9.CrossRefPubMed
9.
go back to reference Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics–2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008;117:e25–146.CrossRefPubMed Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics–2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008;117:e25–146.CrossRefPubMed
10.
go back to reference Ishikawa S, Kayaba K, Gotoh T, et al. Incidence of Total Stroke, Stroke Subtypes, and Myocardial Infarction in the Japanese Population: The JMS Cohort Study. J Epidemiol. 2008;18:144–50.CrossRefPubMed Ishikawa S, Kayaba K, Gotoh T, et al. Incidence of Total Stroke, Stroke Subtypes, and Myocardial Infarction in the Japanese Population: The JMS Cohort Study. J Epidemiol. 2008;18:144–50.CrossRefPubMed
11.
go back to reference Current status of the background of patients with coronary artery disease in Japan. Circ J. 2006;70:1256–62. Current status of the background of patients with coronary artery disease in Japan. Circ J. 2006;70:1256–62.
12.
go back to reference Yamaguchi T, Ishikawa K, Isshiki T, et al. Guidelines for management of acute coronary syndrome without persistent ST segment elevation. Circ J. 2002;66 Suppl IV:1123–63. Yamaguchi T, Ishikawa K, Isshiki T, et al. Guidelines for management of acute coronary syndrome without persistent ST segment elevation. Circ J. 2002;66 Suppl IV:1123–63.
13.
go back to reference Kohro T, Hayashi D, Okada Y, et al. Effects of medication on cardiovascular events in the Japanese coronary artery disease (JCAD) study. Circ J. 2007;71:1835–40.CrossRefPubMed Kohro T, Hayashi D, Okada Y, et al. Effects of medication on cardiovascular events in the Japanese coronary artery disease (JCAD) study. Circ J. 2007;71:1835–40.CrossRefPubMed
14.
go back to reference Yui Y, Hirayama A, Nonogi H, et al. Unstable angina and non-ST elevation acute coronary syndrome: epidemiology and current management in Japan (Japan Multicenter Investigation for Cardiovascular Disease-D (JMIC-D) Committee). Circ J. 2007;71:1335–47.CrossRefPubMed Yui Y, Hirayama A, Nonogi H, et al. Unstable angina and non-ST elevation acute coronary syndrome: epidemiology and current management in Japan (Japan Multicenter Investigation for Cardiovascular Disease-D (JMIC-D) Committee). Circ J. 2007;71:1335–47.CrossRefPubMed
15.
go back to reference Yamazaki T, Goto S, Shigematsu H, et al. Prevalence, awareness and treatment of cardiovascular risk factors in patients at high risk of atherothrombosis in Japan. Circ J. 2007;71:995–1003.CrossRefPubMed Yamazaki T, Goto S, Shigematsu H, et al. Prevalence, awareness and treatment of cardiovascular risk factors in patients at high risk of atherothrombosis in Japan. Circ J. 2007;71:995–1003.CrossRefPubMed
16.
go back to reference Steg PG, Bhatt DL, Wilson PW, et al. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA. 2007;297:1197–206.CrossRefPubMed Steg PG, Bhatt DL, Wilson PW, et al. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA. 2007;297:1197–206.CrossRefPubMed
17.
go back to reference Bhatt DL, Steg PG, Ohman EM, et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA. 2006;295:180–9.CrossRefPubMed Bhatt DL, Steg PG, Ohman EM, et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA. 2006;295:180–9.CrossRefPubMed
18.
go back to reference A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet. 1996;348:1329–39. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet. 1996;348:1329–39.
19.
go back to reference Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;345:494–502.CrossRefPubMed Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;345:494–502.CrossRefPubMed
20.
go back to reference Schwartz GG, Olsson AG, Ezekowitz MD, et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA. 2001;285:1711–8.CrossRefPubMed Schwartz GG, Olsson AG, Ezekowitz MD, et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA. 2001;285:1711–8.CrossRefPubMed
21.
go back to reference GRACE Investigators. Rationale and design of the GRACE (Global Registry of Acute Coronary Events) Project: a multinational registry of patients hospitalized with acute coronary syndromes. Am Heart J. 2001;141:190–9.CrossRef GRACE Investigators. Rationale and design of the GRACE (Global Registry of Acute Coronary Events) Project: a multinational registry of patients hospitalized with acute coronary syndromes. Am Heart J. 2001;141:190–9.CrossRef
22.
go back to reference Hasdai D, Behar S, Wallentin L, et al. A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS). Eur Heart J. 2002;23:1190–201.CrossRefPubMed Hasdai D, Behar S, Wallentin L, et al. A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS). Eur Heart J. 2002;23:1190–201.CrossRefPubMed
Metadata
Title
The PACIFIC (Prevention of AtherothrombotiC Incidents Following Ischemic Coronary attack) Registry: Rationale and Design of a 2-Year Study in Patients Initially Hospitalised with Acute Coronary Syndrome in Japan
Authors
Katsumi Miyauchi
Yoshihiro Morino
Kengo Tsukahara
Hideki Origasa
Hiroyuki Daida
on behalf of the PACIFIC steering committee members
Publication date
01-02-2010
Publisher
Springer US
Published in
Cardiovascular Drugs and Therapy / Issue 1/2010
Print ISSN: 0920-3206
Electronic ISSN: 1573-7241
DOI
https://doi.org/10.1007/s10557-010-6223-2

Other articles of this Issue 1/2010

Cardiovascular Drugs and Therapy 1/2010 Go to the issue